AMED (AMED) Institutional Ownership
None of the superinvestors we track currently report AMED in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in AMED, this page will show institutional holding trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q2 2025 | 1 | $35,823,602 | 364,098 |
| Q1 2025 | 1 | $3,232,787 | 34,900 |
| Q4 2024 | 1 | $3,250,282 | 35,800 |
| Q3 2024 | 2 | $11,793,908 | 122,204 |
| Q2 2024 | 2 | $12,093,273 | 131,735 |
| Q1 2024 | 2 | $341,251 | 172,335 |
| Q4 2023 | 2 | $2,425,328 | 238,955 |
| Q3 2023 | 1 | $6,741,238 | 72,176 |
| Q2 2023 | 1 | $6,913,413 | 75,606 |
| Q1 2023 | 1 | $7,456,573 | 101,381 |
| Q4 2022 | 1 | $4,926,187 | 58,968 |
| Q3 2022 | 1 | $2,715 | 28,051 |
Related AMED Institutional Insights:
- AMED Institutional Ownership & Insiders Activity
- AMED Institutional Ownership & 13F Activity
- AMED Top Institutional Shareholders
- AMED Institutional Buying Activity
- AMED Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- AMED Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings